What You Should Know: - New company Velsera was announced at the J.P. Morgan Healthcare Conference supported by thematic-focused impact fund Summa Equity (“Summa”). - Velsera sets out to amplify the impact of clinicians, researchers and scientists for the benefit of patients around the world. Velsera creates a software platform out of science, technology, and informatics, making data actionable, accelerating the pace and potential of multi-omics. - Velsera, headquartered in
Read More
PierianDx
2bPrecise and PierianDx Team Up to Offer Precision Medicine Solution for Providers
2bPrecise, an EHR-agnostic, cloud-based precision medicine platform, today announced it is collaborating with PierianDx, Inc., the leading clinical genomics knowledge base company, to offer a comprehensive precision medicine solution. The combined solution brings together genomic and clinical data to help providers make more informed care decisions for their patients. This unique technology enables clinicians to concentrate on the most important information to determine what is best for each
Read More
PierianDx Acquires Tute Genomics for Integrated Personalized Medicine
PierianDx, a provider of clinical genomic analysis, interpretation and reporting has acquired Provo, UT-based Tute Genomics. For PierianDx, the acquisition of Tute Genomics’ leading constitutional and exome testing capabilities will provide a single clinical platform for best in class clinical workflow support of somatic cancer and constitutional testing. Financial details of the acquisition were not disclosed.The transaction includes incorporating Tute leadership, advisors and developers into
Read More